AlphaNavi Pharma Inc. (Headquarter: Sakyo-ku, Kyoto, Japan; CEO: Yoshihiro Oyamada) today announced the initia …
AlphaNavi Pharma Inc., (Head Office: Kyoto, Japan; CEO: Yoshihiro Oyamada), which is a start-up company to dev …
AlphaNavi Pharma Inc., (Head Office: Kyoto, Japan; CEO: Yoshihiro Oyamada; hereinafter referred to as “A …
To research about a newly gene-mutated pain disease and to develop a novel analgesic drug for it, AlphaNavi Ph …
A special article on AlphaNavi Pharma Inc. was published in the May 1 issue of Pharmaceutical Economy.
AlphaNavi Pharma Co., Ltd. was nominated for Global University Venturing 2019 “Technology of the Year …